The Versatile Biocatalyst of Cytochrome P450 CYP102A1: Structure, Function, and Engineering

Area of Science:

• Biochemistry
• Biotechnology
• Enzymology

Background:

• Cytochrome P450 CYP102A1 from Bacillus megaterium is a highly efficient, self-sufficient monooxygenase.
• Its unique features, including high catalytic activity and selectivity, make it an ideal biocatalyst.
• Significant progress has been made in engineering CYP102A1 over the past three decades.

Purpose of the Study:

• To review major advances in CYP102A1 structure and function over the last five years.
• To highlight methodologies used for engineering CYP102A1 for novel applications.
• To provide a succinct overview of recent developments in CYP102A1 research.

Main Methods:

• Review of recent literature on CYP102A1 engineering and applications.
• Analysis of structural and functional studies of CYP102A1 variants.
• Compilation of data on expanded substrate scope and catalytic improvements.

Main Results:

• Engineered CYP102A1 variants exhibit expanded substrate repertoires, including alkanes, aromatics, and pharmaceuticals.
• Significant improvements in catalytic activity, regio-, and stereoselectivity have been achieved.
• Novel applications in drug discovery, biosynthesis, and biotechnology have emerged.

Conclusions:

• CYP102A1 engineering continues to yield powerful biocatalysts with diverse applications.
• Recent advances have further solidified CYP102A1's role in synthetic biology and chemical manufacturing.
• Ongoing research promises further expansion of CYP102A1 capabilities and applications.